No Data
No Data
TD Cowen Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $389
Dow's 113-Point Rally Led By Gains For Shares Of Amgen, IBM
DBS Maintains Amgen(AMGN.US) With Buy Rating, Announces Target Price $365
Dow's Decline: Biggest Losers and Winners as Blue-chips Index Faces Q1 Loss
Express News | "Judge Tosses Amgen's Challenge To Colorado Drug Review Board, Says Suit Is 'Too Speculative'" - Endpoints News
Pfizer Ran What Could Be the Largest Tax Dodging Scheme Among Big Pharma: Senator
sGpcGhost : y
102803825 : did you bought when going up?